2-(4-(Benzyloxy)benzyl)-9-(2-ethylhexyl)-1H-purin-6(9H)-one

ID: ALA4580973

Chembl Id: CHEMBL4580973

PubChem CID: 155561694

Max Phase: Preclinical

Molecular Formula: C27H34N4O2

Molecular Weight: 446.60

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCC(CC)CN1C=NC2C(=O)NC(Cc3ccc(OCc4ccccc4)cc3)=NC21

Standard InChI:  InChI=1S/C27H34N4O2/c1-3-5-9-20(4-2)17-31-19-28-25-26(31)29-24(30-27(25)32)16-21-12-14-23(15-13-21)33-18-22-10-7-6-8-11-22/h6-8,10-15,19-20,25-26H,3-5,9,16-18H2,1-2H3,(H,29,30,32)

Standard InChI Key:  TUERUXQAQDTRSA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4580973

    ---

Associated Targets(Human)

PDE5A Tclin Phosphodiesterase 2 and 5 (PDE2 and PDE5) (34 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE10A Tclin Phosphodiesterase 10A (5542 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE9A Tchem Phosphodiesterase 9A (1131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4A Tclin Phosphodiesterase 4 (3344 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE1A Tclin Phosphodiesterase 1 (671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE2A Tclin Phosphodiesterase 2A (1799 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

HT-22 (3261 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 446.60Molecular Weight (Monoisotopic): 446.2682AlogP: 4.59#Rotatable Bonds: 11
Polar Surface Area: 66.29Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.59CX Basic pKa: 4.09CX LogP: 5.27CX LogD: 5.27
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.55Np Likeness Score: -0.05

References

1. Huang XF, Cao YJ, Zhen J, Zhang DW, Kong R, Jiang WT, Xu Y, Song GQ, Ke HM, Liu L..  (2019)  Design, synthesis of novel purin-6-one derivatives as phosphodiesterase 2 (PDE2) inhibitors: The neuroprotective and anxiolytic-like effects.,  29  (3): [PMID:30554955] [10.1016/j.bmcl.2018.12.018]

Source